These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The impact of age on radium-223 distribution and an evaluation of molecular imaging surrogates. Jiang W; Ulmert D; Simons BW; Abou DS; Thorek DLJ Nucl Med Biol; 2018; 62-63():1-8. PubMed ID: 29800797 [TBL] [Abstract][Full Text] [Related]
8. Decreasing undesirable absorbed radiation to the intestine after administration of radium-223 dichloride for treatment of bone metastases. Ogawa K; Higashi T; Mishiro K; Wakabayashi H; Shiba K; Odani A; Kinuya S Sci Rep; 2020 Jul; 10(1):11917. PubMed ID: 32681007 [TBL] [Abstract][Full Text] [Related]
9. Nano-hydroxyapatite radiolabeled with radium dichloride [ Gemini-Piperni S; Ricci-Junior E; İlem-Özdemir D; da Silva Batista B; Alencar LMR; Rossi AM; Santos-Oliveira R Colloids Surf B Biointerfaces; 2023 Mar; 223():113174. PubMed ID: 36746067 [TBL] [Abstract][Full Text] [Related]
10. Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why. Gallicchio R; Mastrangelo PA; Nardelli A; Mainenti PP; Colasurdo AP; Landriscina M; Guglielmi G; Storto G Tumori; 2019 Oct; 105(5):367-377. PubMed ID: 31096849 [TBL] [Abstract][Full Text] [Related]
11. Radium-223 dichloride in clinical practice: a review. Florimonte L; Dellavedova L; Maffioli LS Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1896-909. PubMed ID: 27121689 [TBL] [Abstract][Full Text] [Related]
12. Dosing, administration, and safety of radium-223: How I do it. Dan TD; Doyle L; Raval AJ; Pridjian A; Gomella LG; Den RB Can J Urol; 2016 Jun; 23(3):8301-5. PubMed ID: 27347625 [TBL] [Abstract][Full Text] [Related]
13. New treatment option: 223Ra chloride, the first approved unsealed α-emitting radiopharmaceutical. Colletti PM Clin Nucl Med; 2013 Sep; 38(9):724-5. PubMed ID: 23867617 [TBL] [Abstract][Full Text] [Related]
14. Radium-223 chloride: Extending life in prostate cancer patients by treating bone metastases. Wissing MD; van Leeuwen FW; van der Pluijm G; Gelderblom H Clin Cancer Res; 2013 Nov; 19(21):5822-7. PubMed ID: 24052017 [TBL] [Abstract][Full Text] [Related]
15. FDA approves radiopharmaceutical for metastatic prostate cancer. Cancer Discov; 2013 Jul; 3(7):OF1. PubMed ID: 23847352 [TBL] [Abstract][Full Text] [Related]
16. Ultrastructural Analysis of Cancer Cells Treated with the Radiopharmaceutical Radium Dichloride ([ Diniz Filho JFS; de Barros AODS; Pijeira MSO; Ricci-Junior E; Midlej V; Baroni MPMA; Dos Santos CC; Alencar LMR; Santos-Oliveira R Cells; 2023 Jan; 12(3):. PubMed ID: 36766793 [TBL] [Abstract][Full Text] [Related]
17. Radium Ra 223 dichloride injection: U.S. Food and Drug Administration drug approval summary. Kluetz PG; Pierce W; Maher VE; Zhang H; Tang S; Song P; Liu Q; Haber MT; Leutzinger EE; Al-Hakim A; Chen W; Palmby T; Alebachew E; Sridhara R; Ibrahim A; Justice R; Pazdur R Clin Cancer Res; 2014 Jan; 20(1):9-14. PubMed ID: 24190979 [TBL] [Abstract][Full Text] [Related]
18. Radium Ra 223 dichloride in castration-resistant prostate cancer. Joung JY; Ha YS; Kim IY Drugs Today (Barc); 2013 Aug; 49(8):483-90. PubMed ID: 23977665 [TBL] [Abstract][Full Text] [Related]
20. Radium-223 dichloride: a novel treatment option for castration-resistant prostate cancer patients with symptomatic bone metastases. McGann S; Horton ER Ann Pharmacother; 2015 Apr; 49(4):469-76. PubMed ID: 25573268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]